Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09BLW
|
|||
| Former ID |
DIB012780
|
|||
| Drug Name |
TgAAV-CFTR
|
|||
| Synonyms |
TgAAV-CF; Gene therapy (CFTR), Targeted Genetics; Gene therapy (CFTR), Targeted Genetics/Celltech
Click to Show/Hide
|
|||
| Indication | Cystic fibrosis [ICD-11: CA25; ICD-10: E84, E84.9; ICD-9: 277] | Discontinued in Phase 2 | [1] | |
| Company |
Targeted Genetics Corp
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Chloride channel unspecific (ClC) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011201) | |||
| REF 2 | Novel molecular approaches to cystic fibrosis gene therapy. Biochem J. 2005 April 1; 387(Pt 1): 1-15. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.